← Leaderboards
John L Goudreau
Michigan State University
$3,178,275
Attributed
$3,412,590
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $484.6K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,412,590 · 6
By mechanism
R01$1,429,855 · 1
R21$965,034 · 3
U10$842,537 · 1
T32$175,164 · 1
Top collaborators
- Brian C Schutte1 shared
- Caryl E Sortwell1 shared
Most similar at Michigan State University
Same institution · by research overlap
- Terrie Ellen Taylor$12,968,380
- Norman Peter Reeves$274,132
- Nicholas M Kanaan$11,893,156
- Elahe T Crockett$2,147,148
- Peter J Cobbett$330,669
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseSymptomsDopaminergic NeuronMotorPatternBaseDisabilityMichiganEnrollmentUniversitiesClinical TrialsNeurodegenerative DisordersPharmaceutical PreparationsMovement DisordersDouble-Blind MethodLocationNeuroprotective AgentsNeurologistEtiologyAffectAreaCollaborationsFosteringNeurology
Grant awards (20)
Michigan State University College of Osteopathic Medicine Medical Scientist Training Program (MSTP)$175,164
T32 · FY2025 · GM
BDNF rs6265 and Response to Dopaminergic Therapy in PD$293,467
R21 · FY2016 · NS
The role of Parkin in selective dopamine neuronal degeneration$284,821
R01 · FY2014 · NS · contact PI
MSU Parkinson Disease Clincal Center$112,359
U10 · FY2014 · NS · contact PI
The role of Parkin in selective dopamine neuronal degeneration$277,933
R01 · FY2013 · NS · contact PI
MSU Parkinson Disease Clincal Center$98,347
U10 · FY2013 · NS · contact PI
The role of Parkin in selective dopamine neuronal degeneration$288,310
R01 · FY2012 · NS · contact PI
The role of Parkin in selective dopamine neuronal degeneration$288,591
R01 · FY2011 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$196,004
U10 · FY2011 · NS · contact PI
The role of Parkin in selective dopamine neuronal degeneration$290,200
R01 · FY2010 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$110,124
U10 · FY2010 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$42,600
U10 · FY2010 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$131,370
U10 · FY2009 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$80,763
U10 · FY2008 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$40,770
U10 · FY2007 · NS · contact PI
Neuroprotective factors in hypothalamic dopamine neurons$166,455
R21 · FY2006 · NS · contact PI
Apocynin Neuroprotection in a Parkinson's Disease Model$166,455
R21 · FY2006 · NS · contact PI
Michigan State University Parkinson Disease Clinical Center$30,200
U10 · FY2006 · NS · contact PI
Neuroprotective factors in hypothalamic dopamine neurons$170,837
R21 · FY2005 · NS
Apocynin Neuroprotection in a Parkinson's Disease Model$167,820
R21 · FY2005 · NS